Ingevity Corporation
NGVT
$54.57
-$0.52-0.94%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.44% | -17.64% | -16.88% | -13.19% | -11.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.44% | -17.64% | -16.88% | -13.19% | -11.01% |
| Cost of Revenue | -25.22% | -25.71% | -21.24% | -11.65% | -4.84% |
| Gross Profit | 13.50% | 2.97% | -6.24% | -16.70% | -23.82% |
| SG&A Expenses | -4.06% | -11.01% | -9.46% | -12.62% | -17.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 520.00% | -- | -- | -- |
| Total Operating Expenses | -22.08% | -23.09% | -19.24% | -11.54% | -6.59% |
| Operating Income | 30.24% | 12.90% | -4.78% | -21.19% | -30.29% |
| Income Before Tax | 53.63% | -199.04% | -5,202.97% | -526.89% | -332.47% |
| Income Tax Expenses | 70.75% | -144.41% | -2,140.43% | -468.03% | -293.81% |
| Earnings from Continuing Operations | 49.78% | -215.61% | -7,868.52% | -543.86% | -343.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.78% | -215.61% | -7,868.52% | -543.86% | -343.40% |
| EBIT | 30.24% | 12.90% | -4.78% | -21.19% | -30.29% |
| EBITDA | 15.21% | 4.60% | -5.67% | -16.18% | -20.85% |
| EPS Basic | 49.96% | -214.19% | -6,107.70% | -549.72% | -350.18% |
| Normalized Basic EPS | 136.41% | 26.35% | -34.32% | -55.27% | -64.17% |
| EPS Diluted | 49.93% | -212.72% | -5,228.42% | -553.54% | -352.28% |
| Normalized Diluted EPS | 136.42% | 26.54% | -34.06% | -54.96% | -64.00% |
| Average Basic Shares Outstanding | 0.32% | 0.21% | -0.50% | -1.37% | -2.53% |
| Average Diluted Shares Outstanding | 0.61% | 0.34% | -0.81% | -2.08% | -3.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |